INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 64 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LADENBURG THALMANN FINANCIAL SERVICES INC. | 4,968 | $3,000 | 0.00% |
Renaissance Technologies | 159,900 | $86,000 | 0.00% |